TSE:ACBAurora Cannabis Stock Price, Forecast & News

Aurora Cannabis' stock was trading at C$1.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACB stock has increased by 1,310.3% and is now trading at C$16.50. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Aurora Cannabis.

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, September 9th 2020. View our earnings forecast for Aurora Cannabis.

Aurora Cannabis Inc (TSE:ACB) released its quarterly earnings results on Thursday, May, 14th. The company reported ($0.99) EPS for the quarter, missing analysts' consensus estimates of ($0.70) by $0.29. The company earned $75.52 million during the quarter, compared to the consensus estimate of $63.44 million. View Aurora Cannabis' earnings history.

10 equities research analysts have issued twelve-month price targets for Aurora Cannabis' stock. Their forecasts range from C$2.00 to C$24.00. On average, they expect Aurora Cannabis' stock price to reach C$13.42 in the next twelve months. This suggests that the stock has a possible downside of 18.7%. View analysts' price targets for Aurora Cannabis.

Press coverage about ACB stock has been trending negative on Friday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Aurora Cannabis earned a news sentiment score of -2.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Aurora Cannabis.

Some companies that are related to Aurora Cannabis include Hikma Pharmaceuticals (HIK), Evotec (EVT), Aphria (APHA), Knight Therapeutics (GUD), Ecofibre (EOF), HLS Therapeutics (HLS), Hexo (HEXO), OrganiGram (OGI), HEXO (HEXO), Next Science (NXS), Amryt Pharma (AMYT), ICC Labs (ICC), Benchmark (BMK), ESSA Pharma (EPI) and Probiotec (PBP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACBFF), OrganiGram (OGI), Cronos Group (CRON), Green Organic Dutchman (TGOD), Micron Technology (MU), Alibaba Group (BABA) and Advanced Micro Devices (AMD).

Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

One share of ACB stock can currently be purchased for approximately C$16.50.

Aurora Cannabis has a market capitalization of C$1.86 billion and generates C$305.73 million in revenue each year. Aurora Cannabis employs 967 workers across the globe.

The official website for Aurora Cannabis is auroramj.com.

Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.